A preliminary report of increased plasma levels of IL-33 in bipolar disorder: Further evidence of pro-inflammatory status
A preliminary report of increased plasma levels of IL-33 in bipolar disorder: Further evidence of pro-inflammatory status
复制标题
DOI:
10.1016/j.jad.2013.12.042
复制
发表时间:
2014-03-20
影响因子:
6.6
通讯作者:
Teixeira, Antonio Lucio
中科院分区:
文献类型:
--
作者:
Barbosa, Izabela Guimaraes;Morato, Isabela Boechat;Teixeira, Antonio Lucio
Background: Recent findings suggest an important role for inflammation in the neurobiology of bipolar disorder (BD). Interleukin 33 (IL-33) is a cytokine with multiple functions and may act as a nuclear factor regulating transcription and as an "alarmin". IL-33 exerts part of its function through the receptor ST2 that also exists in a soluble form (sST2). This study was performed to evaluate IL-33 and sST2 plasma levels in BD patients.Methods: We evaluated IL33 and sST2 plasma levels of 46 BD patients (23 in euthymia and 23 in mania) and 23 healthy controls using enzyme-linked immunosorbent assay (ELISA). BD patients were age and gender matched healthy controls.Results: IL-33 levels were higher in BD patients (p=0.02) but there was no difference in sST2 (p=0.55). IL33 and sST2 plasma levels were not correlated with age, neither was influenced by clinical comorbidities nor medications in use.Conclusion: These findings corroborate the view of BD as a multisystem condition with a proinflammatory profile. (C) 2014 Elsevier B.V. All rights reserved.